Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

The Delaware Supreme Court ruled in favor of companies including GSK (NYSE:GSK), Pfizer (NYSE:PFE), and Boehringer Ingelheim on Thursday, rejecting the legitimacy of expert testimony that linked tens ...

An Illinois appellate court upheld the dismissal of negligence and liability claims against manufacturers of generic Zantac, affirming a lower court’s ruling that the liability counts were pre-empted ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. By Rebecca Robbins The British drug maker GSK said on Wednesday that it ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen. The ...

Delaware—the first of the 13 colonies to ratify the U.S. Constitution—also prides itself on being the state of incorporation for "more than 66% of the Fortune 500." The Delaware Supreme Court recently ...

Sixteen plaintiffs' allegations against Big Pharma stand after a judge denied the companies' motion to dismiss. The plaintiffs claim that they developed cancer due to the medication Zantac, which is ...

A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...

A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer. The ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar ...